NCT04543188 2025-10-23A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain InvolvementPfizerPhase 1 Terminated65 enrolled 52 charts
NCT03690869 2025-04-08REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent GliomaRegeneron PharmaceuticalsPhase 1/2 Terminated57 enrolled 31 charts
NCT03451825 2024-06-24Phase I/II Study of Avelumab in Pediatric Cancer ParticipantsEMD SeronoPhase 1 Terminated21 enrolled 21 charts
NCT01295697 2022-02-14Study of EZN-2208 Pediatric Patients With Solid TumorsEnzon Pharmaceuticals, Inc.Phase 1/2 Terminated32 enrolled